A PHASE 2B RANDOMIZED STUDY OF SINGLE AGENT SELINEXOR IN PATIENTS WITH RELAPSED/REFRACTORY DIFFUSE LARGE B-CELL LYMPHOMA (DLBCL)

التفاصيل البيبلوغرافية
العنوان: A PHASE 2B RANDOMIZED STUDY OF SINGLE AGENT SELINEXOR IN PATIENTS WITH RELAPSED/REFRACTORY DIFFUSE LARGE B-CELL LYMPHOMA (DLBCL)
المؤلفون: Marie Maerevoet, Jason R. Westin, Jean-Richard Saint-Martin, E. Van Den Neste, B. Wrigley, John Kuruvilla, George A. Follows, Marissa Devlin, Miguel Canales, Josée M. Zijlstra, Michael Kauffman, J. Meade, Sharon Shacham, René-Olivier Casasnovas, Sylvain Choquet, Brian T. Hill, F. de la Cruz Vicente, C. Nippgen, Paolo Caimi, Catherine Thieblemont, Jason B. Kaplan, Humphrey Gardner
المصدر: Hematological Oncology. 35:191-192
بيانات النشر: Wiley, 2017.
سنة النشر: 2017
مصطلحات موضوعية: Oncology, Cancer Research, medicine.medical_specialty, business.industry, Hematology, General Medicine, medicine.disease, law.invention, Randomized controlled trial, law, Internal medicine, Relapsed refractory, medicine, In patient, Single agent, business, Diffuse large B-cell lymphoma
تدمد: 0278-0232
URL الوصول: https://explore.openaire.eu/search/publication?articleId=doi_________::309d9abfc29aa5f74190842e9ad970b8
https://doi.org/10.1002/hon.2438_53
حقوق: OPEN
رقم الأكسشن: edsair.doi...........309d9abfc29aa5f74190842e9ad970b8
قاعدة البيانات: OpenAIRE